
Sign up to save your podcasts
Or
On this week’s Tech Nation, Moira speaks with Dr. Robert Ang, the President & CEO of Vor Biopharma, about its approach to Acute Myeloid Leukemia, also known as AML. Then, Dr. Nik Sopko, the chief scientific officer of PolarityTE, talked about their design for wound healing. Their first treatment candidate is diabetic foot ulcers, and Dr. Eric Vivier from Innate Pharma in Marseilles tells us about the next wave of immunotherapy treatments – harnessing Natural Killer cells.
4.4
6060 ratings
On this week’s Tech Nation, Moira speaks with Dr. Robert Ang, the President & CEO of Vor Biopharma, about its approach to Acute Myeloid Leukemia, also known as AML. Then, Dr. Nik Sopko, the chief scientific officer of PolarityTE, talked about their design for wound healing. Their first treatment candidate is diabetic foot ulcers, and Dr. Eric Vivier from Innate Pharma in Marseilles tells us about the next wave of immunotherapy treatments – harnessing Natural Killer cells.
6,241 Listeners
696 Listeners
466 Listeners
927 Listeners
38,686 Listeners
44,077 Listeners
90,378 Listeners
38,038 Listeners
30,752 Listeners
32,157 Listeners
939 Listeners
43,883 Listeners
389 Listeners
2,133 Listeners
1,631 Listeners